Health and Healthcare Systems

This is how man and machine can work together to diagnose disease

Nurse Health Practitioner Rachelle Quimpo (C) views a mole on patient Shreya Sasaki as Dr. Heidi Meyer, MD Family Medicine, remotely views the procedure on a video screen at a newly opened  Kaiser Permanente health clinic inside a Target retail department store in San Diego, California November 17, 2014. Four clinics are scheduled to open in Southern California to provide pediatric and adolescent care, well-woman care, family planning, and management of chronic conditions like diabetes and high blood pressure for Kaiser members and non-members. REUTERS/Mike Blake (UNITED STATES - Tags: HEALTH BUSINESS SOCIETY SCIENCE TECHNOLOGY)

Researchers at Stanford showed that machines were just as accurate as trained dermatologists Image: REUTERS/Mike Blake

Anant Madabhushi
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Health and Healthcare Systems?
The Big Picture
Explore and monitor how Health and Healthcare is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Health and Healthcare

With artificial intelligence, machines can now examine thousands of medical images – and billions of pixels within these images – to identify patterns too subtle for a radiologist or pathologist to identify.

The machine then uses this information to identify the presence of a disease or estimate its aggressiveness, likelihood of survival or potential response to treatment.

We are engineers at the Center for Computational Imaging and Personalized Diagnostics. Our team works with physicians and statisticians to develop and validate these kinds of tools.

Many worry that this technology aims to replace doctors. But we believe the technology will work in tandem with humans, making them more efficient and helping with decisions on complicated cases.

Machine learning and medical images

In one study, researchers at Stanford showed that machines were just as accurate as trained dermatologists in distinguishing skin cancers from benign lesions in 100 test images.

In another, computer scientists at Google used an AI approach called deep learning to accurately identify which patients had diabetic retinopathy – a constellation of changes in the retina due to diabetes – from high-resolution photographs of the retina. Another deep learning project at Google successfully predicted cardiovascular disease risk from retina images.

Our group has been developing new ways to identify disease in scans like MRI and CT, as well as digitized tissue slide images.

In biopsied images of heart tissue from 105 patients with heart disease, our algorithms predicted with high accuracy which patients would go on to have heart failure.

In another study involving MRI scans from prostate cancer patients, our computer algorithms identified clinically significant disease in more than 70 percent of cases where radiologists missed it. In half of the cases where radiologists mistakenly thought that the patient had aggressive prostate cancer, the machine was able to correctly identify that no clinically significant disease was present.

 A CT scan showing cancer in the eye.
Image: Wellcome Collection

Our team has also been developing approaches to predict a patient’s response to specific therapies and monitor early treatments.

Take the case of immunotherapy. Immunotherapy drugs boost the body’s own immune defenses to fight against the cancer. They have shown tremendous promise in comparison to traditional chemotherapy, but certain caveats limit their widespread use. Only about 1 in 5 patients with lung cancer might actually respond to immunotherapy regimens. Additionally, these therapies cost upwards of US$200,000 per patient per year and can have toxic effects on the immune system. Physicians need a way to determine accurately which patients might benefit.

To identify the likelihood of a successful response before therapy begins, our lab is building software to examine routine diagnostic CT scans of lung tumors. The software looks at tumor texture, intensity and shape, as well as the shape of vessels feeding the nodules. This information might help oncologists optimize the therapy dosage or alter a patient’s treatment plan.

There are many cancers and other diseases where computational tools to predict disease aggressiveness or treatment response could aid physicians. For example, a study published this June compared women with breast cancer who had been treated with adjuvant chemotherapy or standard endocrine therapy. For about 70 percent of the patients, the chemotherapy had no demonstrated benefit compared to the standard approach. Preventing unnecessary and often deleterious chemotherapy thus becomes a key issue for doctors. However, currently, the only way to predict outcome depends upon expensive genomic tests that destroy tissue.

We are currently working on a new way to interrogate digitized tissue images from biopsies of the breast. Our new project, starting this year, will test the technology on women with breast cancers at Tata Memorial Hospital in Mumbai, India.

Making it possible

There is a massive opportunity for clinicians, radiologists and pathologists to enrich their decisions with artificial intelligence. That’s particularly true when it comes to building treatment plans tailored to the individual patient.

Before such technology can be used in hospitals, researchers like ourselves need to do further tests to ensure it’s reliable and valid. This can be done by carrying out tests at multiple medical institutions.

It’s also important for physicians to be able to interpret the technology. They’re unlikely to adopt technology that cannot be explained by existing biology research. For example, our lung tumor software looks at vessel shape because studies show that the degree of convolutedness of the vessels feeding the tumor can negatively affect drug delivery.

That’s why it’s crucial artificial intelligence researchers like ourselves engage clinicians early in the development process as equal collaborators.

Have you read?
Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Childhood obesity – how do we tackle this worsening health issue?

Shyam Bishen

August 30, 2024

About Us

Events

Media

Partners & Members

  • Sign in
  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum